Synthelabo presents new 5-HT1A inverse agonist with antagonist and anxiolytic-like activity in vivo Nov. 11, 1998
LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner Nov. 11, 1998
Knoll develops potential new antipsychotic agent with advantages over available therapies Nov. 10, 1998
Cevimeline improves symptoms of xerostomia in animal models, patients with Sjogren's syndrome Nov. 10, 1998
RSS